FOSRENOL

Medicinal product

(Invented) name

FOSRENOL

Active substance (s)

Lantanas

Strength

250 mg

Pharmaceutical form

kramtomosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AE03, Lanthanum carbonate

Marketing authorisation holder

Takeda Pharmaceuticals International AG Ireland Branch, Airija

Date of authorisation

2007-10-03

Date of renewal

2015-02-12

Documents

0776 Pakuotės lapelis 2025 04 04.docx

0776 FOSRENOL PCS PL 2025 04 04.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

SE/H/0481/001/E/001

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Lantanas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
23817	26500	1026500	buteliukas	N90		Receptinis	LT/1/07/0776/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2015-02-12	Perregistruotas
2007-10-03	Registruotas